SOLAR-PROMOTION
2.5.2024 14:40:32 CEST | Business Wire | Press release
E-mobility is about much more than driving on climate-neutral electricity from renewable sources. The batteries of electric vehicles can be used as temporary storage. And it’s not just vehicle owners who benefit from this: In the medium-term, bidirectional charging can take the burden off distribution grids while making them more flexible. Power2Drive Europe, the international exhibition for charging infrastructure and e-mobility, showcases the latest state of the art. As part of The smarter E Europe, the continent’s largest alliance of exhibitions for the energy industry, it will take place from June 19–21, 2024, at Messe München. The Power2Drive Europe Conference, the industry's meeting point and forum for exchange and discourse among experts, stakeholders, and thought leaders in the new mobility sector, kicks off one day earlier.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240502196803/en/
Power2Drive Europe 2024 highlights cutting-edge trends and technologies in bidirectional charging. Credit: Solar Promotion GmbH
There are three types of applications that bidirectional charging of EV traction batteries can be used for: In vehicle-to-home (V2H) and vehicle-to-building (V2B) solutions, the storage and consumption of the electricity takes place entirely in the user’s system, meaning in a private household or a company, behind the meter. In vehicle-to-grid (V2G) solutions, the e-car is part of the power system and can provide flexibility services to the distribution grid by storing electricity and feeding it back into the grid.
Potentials of bidirectional charging
A study conducted by NRW.Energy4Climate and e-mobil BW forecasts that by 2035, approximately 33 million battery electric vehicles could be on the roads in Germany. Of these vehicles, about 65 percent are projected to support bidirectional charging. This translates to a potential of around 7.6 million vehicles serving as mobile energy storage units. Remarkably, this capacity, reaching up to 380 gigawatt-hours, surpasses the demand for stationary battery storage by threefold. These findings underscore the significant potential of electromobility in facilitating the integration of renewable energies.
V2G and regulatory requirements
The basic regulatory legal framework is still missing for the V2G solutions that are immediately useful for the grid to work. Markus Elsässer explains that “Bidirectional charging will be a decisive element of the energy transition. The technology has the potential of effectively taking the burden off distribution grids and making the more flexible.”
Markus Fendt, Managing Director of The Mobility House, emphasizes the societal and economic importance of this application: “V2G bidirectional charging dramatically reduces redispatch. Based on the price of electricity alone, every electric car could have been driven 40,000 kilometers at no extra cost in 2022. It also reduces the need for grid expansion. And last but not least, we would realize innovation in our leading industry, the automotive industry, in Germany.
Power2Drive Europe sees massive growth
Within the range of topics at The smarter E Europe, e-mobility is becoming more important and recognized: In a survey, a third of the trade visitors of all exhibitions of The smarter E Europe expressed an interest in the topic e-mobility. Consequently, the exhibition space of Power2Drive Europe has been expanded by 80 percent compared to the previous year.
Power2Drive Europe
Power2Drive Europe is the international exhibition for charging infrastructure and e-mobility. Under the motto “Charging the Future of Mobility”, it is the ideal industry meeting point for players from the world of sustainable mobility. The focus is on charging infrastructure, electromobility, mobility services and sector coupling. Power2Drive Europe will take place from June 19–21, 2024 as part of The smarter E Europe at Messe München.
More information: www.powertodrive.de
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240502196803/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom